Murase N et al. |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. |
1993 |
Transplant. Proc. |
pmid:7679817
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Starzl TE |
FK 506 versus cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679820
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Mañez R et al. |
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7680170
|
McCauley J |
The nephrotoxicity of FK506 as compared with cyclosporine. |
1993 |
Curr. Opin. Nephrol. Hypertens. |
pmid:7532089
|
Müller MK et al. |
[Pathophysiologic concepts and protective possibilities in experimental pancreatic lesions]. |
1993 |
Z Gastroenterol |
pmid:7504856
|
Panis Y and Valleur P |
[Small intestine transplantation. Experimental and clinical results]. |
1993 |
Ann Chir |
pmid:7504899
|
Tsai M et al. |
Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. |
1993 |
Eur. J. Immunol. |
pmid:7504992
|
Hendrickson BA et al. |
Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1. |
1993 |
Gene |
pmid:7505249
|
Lundemose AG et al. |
Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. |
1993 |
Mol. Microbiol. |
pmid:7682281
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Deardon DJ et al. |
Small bowel tonometry: a possible technique for detecting early small bowel allograft dysfunction. |
1993 |
Transplant. Proc. |
pmid:7505502
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Klintmalm GB et al. |
Rejection: FK 506 for rescue or maintenance. |
1993 |
Transplant. Proc. |
pmid:7682356
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Woodle ES et al. |
FK 506 rescue therapy: early conversion improves efficacy. |
1993 |
Transplant. Proc. |
pmid:7682359
|
McDiarmid SV et al. |
FK506 conversion for intractable rejection of the liver allograft. |
1993 |
Transpl. Int. |
pmid:7507675
|
Tokunaga Y et al. |
Living related liver transplantation across ABO blood groups with FK506 and OKT3. |
1993 |
Transpl. Int. |
pmid:7507676
|
Winkler M et al. |
Conversion from cyclosporin to FK 506 after liver transplantation. |
1993 |
Transpl. Int. |
pmid:7507677
|
David M et al. |
[Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. |
1993 |
Zentralbl Gynakol |
pmid:7692689
|
Wallemacq PE and Reding R |
FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. |
1993 |
Clin. Chem. |
pmid:7693372
|
Nakamura T et al. |
Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. |
1993 |
EMBO J. |
pmid:7693452
|
Higa A et al. |
Attenuation of epithelial injury in acute experimental colitis by immunomodulators. |
1993 |
Eur. J. Pharmacol. |
pmid:7693488
|
Schmitt J et al. |
Cloning and expression of a mouse cDNA encoding p59, an immunophilin that associates with the glucocorticoid receptor. |
1993 |
Gene |
pmid:7693550
|
Schwaninger M et al. |
The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. |
1993 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7509460
|
Takeda Y et al. |
Stimulation of endothelin mRNA and secretion in human endothelial cells by FK 506. |
1993 |
J. Cardiovasc. Pharmacol. |
pmid:7509973
|
Dickey JB et al. |
Periocular FK-506 delays allograft rejection in rat penetrating keratoplasty. |
1993 |
Cornea |
pmid:7684663
|
Francavilla A et al. |
Hepatic regeneration and growth factors. |
1993 |
J Surg Oncol Suppl |
pmid:7684910
|
Connelly PR et al. |
Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O. |
1993 |
Biochemistry |
pmid:7684925
|
Wallemacq PE et al. |
Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 hours. |
1993 |
Clin. Chem. |
pmid:7684956
|
Mochizuki M et al. |
A clinical trial of FK506 in refractory uveitis. |
1993 |
Am. J. Ophthalmol. |
pmid:7685147
|
Thomson AW et al. |
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. |
1993 |
Springer Semin. Immunopathol. |
pmid:7686690
|
Koga T et al. |
Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. |
1993 |
Chest |
pmid:7686837
|
Nishi M et al. |
Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7686893
|
Nishizawa S et al. |
Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. |
1993 |
Neurosurgery |
pmid:7687044
|
Warty V et al. |
FK506 measurement: comparison of different analytical methods. |
1993 |
Ther Drug Monit |
pmid:7687389
|
Odocha O et al. |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689269
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Jost U et al. |
FK 506 treatment of intractable rejection after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689276
|
Hacker J and Fischer G |
Immunophilins: structure-function relationship and possible role in microbial pathogenicity. |
1993 |
Mol. Microbiol. |
pmid:7526121
|
Whitington PF et al. |
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. |
1993 |
Lancet |
pmid:7690444
|
Takahashi H and Iizuka H |
Neither cyclosporin A nor FK506 affects adenylate cyclase responses of fetal rat keratinizing epidermal cells (FRSK cells) at concentrations that inhibit thymidine incorporation. |
1993 |
J. Dermatol. Sci. |
pmid:7511000
|